Autism Spectrum Disorder: Pathophysiology and Treatment Implications

[1]

Anderson G, Medina SRB. Autism spectrum disorders: role of pre- and post-natal GammaDelta (γδ) T cells and immune regulation. Curr Pharm Des 2019; 25(41): 4321-30.

[2]

Beversdorf DQ, Stevens HE, Margolis KG, Van de Water J. Prenatal stress and maternal immune dysregulation in autism spectrum disorders: potential points for intervention. Curr Pharm Des 2019; 25(41): 4331-43.

[3]

Seo M, Anderson G. Gut-amygdala interactions in autism spectrum disorders: developmental roles via regulating mitochondria, exosomes, immunity and microRNAs. Curr Pharm Des 2019; 25(41): 4344-56.

[4]

Alzghoul L. Role of vitamin D in autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4357-67.

[5]

Mahesh MV, Puthiripadath SS, Parakkal R, Ismail T, Ayyappan A. microRNAs in autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4368-78.

[6]

Pinato L, Spilla CSG, Campos LMG, Markus RP, da Silveira Cruz-Machado S. Dysregulation of circadian rhythms in autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4379-93.

[7]

Telias M. Pharmacological treatments for fragile X syndrome based on synaptic dysfunction. Curr Pharm Des 2019; 25(41): 4394-404.

[8]

Maes M, Anderson G, Medina SRB, Seo M, Ojala JO. Integrating autism spectrum disorder pathophysiology: mitochondria, vitamin A, CD38, oxytocin, serotonin and melatonergic alterations in the placenta and gut. Curr Pharm Des 2019; 25(41): 4405-20.

[9]

Kardani A, Soltani A, Sewell RDE, Shahrani M, Rafieian-Kopaei M. Neurotransmitter, antioxidant and anti-neuroinflammatory mechanistic potentials of herbal medicines in ameliorating autism spectrum disorder. Curr Pharm Des 2019; 25(41): 4421-9.

[10]

Pacheva I, Ivanov I. Targeted biomedical treatment for autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4430-53.

[11]

Ruggieri V, Cuesta Gómez JL, Martínez MM, Arberas C. Aging and autism: understanding, intervention, and proposals to improve quality of life. Curr Pharm Des 2019; 25(41): 4454-61.